These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4157350)

  • 21. The synthesis of polyphenylalanine on ribosomes to which erythromycin is bound.
    Odom OW; Picking WD; Tsalkova T; Hardesty B
    Eur J Biochem; 1991 Jun; 198(3):713-22. PubMed ID: 1904819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elongating ribosomes in vivo are refractory to erythromycin.
    Andersson S; Kurland CG
    Biochimie; 1987 Aug; 69(8):901-4. PubMed ID: 3122850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding to ribosomes and mode of action of chloramphenicol analogues.
    Contreras A; Barbacid M; Vazquez D
    Biochim Biophys Acta; 1974 May; 349(3):376-88. PubMed ID: 4601418
    [No Abstract]   [Full Text] [Related]  

  • 24. Release of (oligo) peptidyl-tRNA from ribosomes by erythromycin A.
    Otaka T; Kaji A
    Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2649-52. PubMed ID: 1101261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes.
    de Bethune MP; Nierhaus KH
    Eur J Biochem; 1978 May; 86(1):187-91. PubMed ID: 95947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties of ribosomes from Streptomyces erythreus and Streptomyces griseus.
    Teraoka H; Tanaka K
    J Bacteriol; 1974 Oct; 120(1):316-21. PubMed ID: 4138441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation in gram-postive and gram-negative bacteria as a mechanism of resistance to erythromycin.
    Mao JC; Putterman M
    J Bacteriol; 1968 Mar; 95(3):1111-7. PubMed ID: 4966821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of erythromycin to the 50S ribosomal subunit is affected by alterations in the 30S ribosomal subunit.
    Saltzman L; Apirion D
    Mol Gen Genet; 1976 Feb; 143(3):301-6. PubMed ID: 765762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precursor directed biosynthesis of an orthogonally functional erythromycin analogue: selectivity in the ribosome macrolide binding pocket.
    Harvey CJ; Puglisi JD; Pande VS; Cane DE; Khosla C
    J Am Chem Soc; 2012 Jul; 134(29):12259-65. PubMed ID: 22741553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The polypeptide tunnel system in the ribosome and its gating in erythromycin resistance mutants of L4 and L22.
    Gabashvili IS; Gregory ST; Valle M; Grassucci R; Worbs M; Wahl MC; Dahlberg AE; Frank J
    Mol Cell; 2001 Jul; 8(1):181-8. PubMed ID: 11511371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aromatic esters of 5-O-desosaminylerythronolide A oxime.
    LeMahieu RA; Carson M; Kierstead RW; Pestka S
    J Med Chem; 1975 Aug; 18(8):849-51. PubMed ID: 808612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of erythromycin base and erythromycin esters on protein synthesis in vivo in Escherichia coli.
    Andersson SG; Kurland CG
    J Antimicrob Chemother; 1988 Nov; 22(5):605-12. PubMed ID: 3061998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of antibiotics on the substrate binding to the acceptor and donor site of ribosomal peptidyltransferase of an erythromycin-resistant mutant of Escherichia coli.
    Cerná J; Rychlík I
    Biochim Biophys Acta; 1972 Dec; 287(2):292-300. PubMed ID: 4609472
    [No Abstract]   [Full Text] [Related]  

  • 35. Properties of ribosomes from erythromycin resistant mutants of Escherichia coli.
    Pardo D; Rosset R
    Mol Gen Genet; 1977 Nov; 156(3):267-71. PubMed ID: 340907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mode of action of griseoviridin at the ribosome level.
    Barbacid M; Contreras A; Vazquez D
    Biochim Biophys Acta; 1975 Jul; 395(3):347-54. PubMed ID: 1096949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of macrolide antibiotics on the ribosomal peptidyl transferase in cell-free systems derived from Escherichia coli B and erythromycin-resistant muytant of Escherichia coli B.
    Cerná J; Jonák J; Rychlík I
    Biochim Biophys Acta; 1971 Jun; 240(1):109-21. PubMed ID: 4940152
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythromycin-resistant mutant of Escherichia coli with altered ribosomal protein component.
    Tanaka K; Teraoka H; Tamaki M; Otaka E; Osawa S
    Science; 1968 Nov; 162(3853):576-8. PubMed ID: 4886608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross resistance of Escherichia coli B. ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Rychlík I; Cerná J
    Hoppe Seylers Z Physiol Chem; 1968 Aug; 349(8):958-9. PubMed ID: 4878426
    [No Abstract]   [Full Text] [Related]  

  • 40. Nuclear magnetic resonance studies on the mode of action of erythromycin A.
    Gyi JI; Barber J
    Biochem Soc Trans; 1991 Aug; 19(3):313S. PubMed ID: 1783149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.